Beken Bio develops surgical fluid tests that help diagnose cancer.
Beken Bio has raised $1.3M in total funding. The most recent round was Grant. The last funding was announced in August 2026.
Beken Bio's investors include National Science Foundation, Boot64 Ventures, 1834 Ventures, Curebound, New Orleans BioFund.
Beken Bio is headquartered in San Diego, United States.
Beken Bio develops surgical fluid tests that help diagnose cancer.
Beken Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Beken Bio — Funding & Investors." VCBacked, August 11, 2026, https://www.vcbacked.co/company/beken-bio. Accessed September 30, 2026.
VCBacked. (2026). Beken Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/beken-bio
{{cite web |title=Beken Bio — Funding & Investors |url=https://www.vcbacked.co/company/beken-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated